JPMorgan analyst Chris Schott says Eli Lilly’s Q4 miss represents a buying opportunity as the company is positioned for strong growth in 2025. The company’s 2025 sales guidanc ...

Liontrust’s assets under management dropped by 5.3% to £24.6bn at the end of December 2024 following “concentrated” outflows.

Alongside the company’s results, Liontrust announced that its Sustainable Investment team’s suite of 10 UK-domiciled funds, ...

Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

Fund returned -10.92% vs. -7.86% for the MSCI World ex USA Small Cap Index (net) for the quarter. Since its inception in ...

Marshall Witt; Chief Financial Officer; TD Synnex Corp Ruplu Bhattacharya; Analyst; BofA Securities, Inc. Ashish Sabadra; Analyst; RBC Capital Markets George Wang; Analyst; Barclays Investment Bank ...

Zevia PBC ("Zevia" or the "Company") (NYSE: ZVIA), the Company bringing naturally delicious, zero sugar, clean-label ...

Q4 2024 Earnings Call Transcript January 10, 2025 TD SYNNEX Corporation misses on earnings expectations. Reported EPS is $2.3 ...

London-based Liontrust Asset Management has said it plans to cut more jobs after revealing net outflows of £1.6bn for the ...

Investment analysts at Telsey Advisory Group dropped their Q3 2026 EPS estimates for Nordstrom in a report released on Monday ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

Sula Vineyards' Q3 business update reveals a 0.7% dip in net revenue to ₹217.3 crore, while wine tourism surged 11.5%, ...